353 related articles for article (PubMed ID: 16184196)
1. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
Bai S; Kitaura H; Zhao H; Chen J; Müller JM; Schüle R; Darnay B; Novack DV; Ross FP; Teitelbaum SL
J Clin Invest; 2005 Oct; 115(10):2742-51. PubMed ID: 16184196
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts.
Bai S; Zha J; Zhao H; Ross FP; Teitelbaum SL
J Biol Chem; 2008 Nov; 283(45):30861-7. PubMed ID: 18768464
[TBL] [Abstract][Full Text] [Related]
3. Self-assembled RANK induces osteoclastogenesis ligand-independently.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 Nov; 20(11):2053-60. PubMed ID: 16234979
[TBL] [Abstract][Full Text] [Related]
4. RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis.
Gohda J; Akiyama T; Koga T; Takayanagi H; Tanaka S; Inoue J
EMBO J; 2005 Feb; 24(4):790-9. PubMed ID: 15678102
[TBL] [Abstract][Full Text] [Related]
5. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
6. Signaling crosstalk between RANKL and interferons in osteoclast differentiation.
Takayanagi H; Kim S; Taniguchi T
Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S227-32. PubMed ID: 12110142
[TBL] [Abstract][Full Text] [Related]
7. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Boyce BF; Xing L
J Bone Miner Res; 2004 Feb; 19(2):207-13. PubMed ID: 14969390
[TBL] [Abstract][Full Text] [Related]
8. Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
Tomomura M; Suzuki R; Shirataki Y; Sakagami H; Tamura N; Tomomura A
PLoS One; 2015; 10(6):e0130174. PubMed ID: 26083531
[TBL] [Abstract][Full Text] [Related]
9. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
10. Dimer formation of receptor activator of nuclear factor kappaB induces incomplete osteoclast formation.
Iwamoto K; Miyamoto T; Sawatani Y; Hosogane N; Hamaguchi I; Takami M; Nomiyama K; Takagi K; Suda T
Biochem Biophys Res Commun; 2004 Dec; 325(1):229-34. PubMed ID: 15522223
[TBL] [Abstract][Full Text] [Related]
11. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
12. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
13. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6.
Yasui T; Kadono Y; Nakamura M; Oshima Y; Matsumoto T; Masuda H; Hirose J; Omata Y; Yasuda H; Imamura T; Nakamura K; Tanaka S
J Bone Miner Res; 2011 Jul; 26(7):1447-56. PubMed ID: 21305609
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
15. The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.
Wang MW; Wei S; Faccio R; Takeshita S; Tebas P; Powderly WG; Teitelbaum SL; Ross FP
J Clin Invest; 2004 Jul; 114(2):206-13. PubMed ID: 15254587
[TBL] [Abstract][Full Text] [Related]
16. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation.
Lamothe B; Webster WK; Gopinathan A; Besse A; Campos AD; Darnay BG
Biochem Biophys Res Commun; 2007 Aug; 359(4):1044-9. PubMed ID: 17572386
[TBL] [Abstract][Full Text] [Related]
17. Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis.
De Klerck B; Carpentier I; Lories RJ; Habraken Y; Piette J; Carmeliet G; Beyaert R; Billiau A; Matthys P
Arthritis Res Ther; 2004; 6(3):R220-31. PubMed ID: 15142268
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
20. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T
Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
